2nd Quarter - Report

LMH STRATEGIC SOLUTIONS for ARDELYX, INC.

Period 2nd Quarter 2026 Filed Jul 5, 2026 Signed by Beth Anne Cole

Official filing
Firm
LMH STRATEGIC SOLUTIONS
Client
ARDELYX, INC.
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

General health care coverage and reimbursement for prescription drugs.

LobbyistCovered position, as disclosed
ALANNA TEMME Legislative Director, U.S. Representative Jon Porter
MAXIMILIAN WALTER —

Contacted: Health & Human Services, Dept of (HHS); SENATE; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES

Pharmacy PHA

General health care coverage and reimbursement for prescription drugs. Drug pricing reform. Food and Drug Administration legislative and regulatory issues.

LobbyistCovered position, as disclosed
ALANNA TEMME —
MAXIMILIAN WALTER —

Contacted: Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.